Looking forward, with the dual roles of TNF - α and the potential of TNFR2 as a therapeutic target, further comprehensive and long-term studies are warranted to clarify their precise mechanisms in CRC, optimize related therapies, and ultimately improve the prognosis for colorectal cancer patients. The gene discussed is TNFRSF1B; the disease is colorectal carcinoma.